In this Gene Scene, Katherine Crawford covers gene-disease validity in the CALM2 gene including CALM2–related calmodulinopathy with clinical considerations for genetic counselors. Dive deeper: https://t.co/9d3Ejynh8b #GeneScene #GeneChat

Headed to #AMCG2026? Meet the experts at our booth. Set up a meeting here: https://t.co/DoLauBtu6g Thursday, March 12: 3:00 - 4:00pm Carrie Horton, MS: In her role as a Clinical Strategy Manager for Research and Collaborations, Carrie works to aligning our research strategies

From the Nasdaq tower to our long-term roadmap, momentum is building. Investors, follow Xanadu’s progress through $CHAC. Get the highlights from our first Analyst Day.

Are you a pediatric NP working in primary care, developmental pediatrics, or autism‑focused settings who wants to better understand how genetic testing can support earlier diagnoses, guide care decisions, and improve outcomes for your patients and their families? Register now for

We are looking forward to #ACMG2026 and discussing where genomic insights meet clinical action. Meet Seth Berger, MD, PhD, Translational Genomics Director for Rare Disease in Research and Development at Ambry and get a sneak peak of industry insights in this blog and then ask him

Don't miss our exhibit theater presentation on Friday, March 13. Join Dr. Altovise Ewing-Crawford, Dr. Seth Berger, and Carrie Horton, MS, CGC to explore laboratory-led initiatives that improve equity in genomic testing. Check out all of our scientific posters or make an

Caitlin Reid, MS, LGC, explores RB1 and its association with RBI-related retinoblastoma in this weekly snapshot of clinically actionable genes from the ACMG Secondary Findings List. Dive deeper: https://t.co/n6ugON6kn9 #GeneScene

Ambry Genetics is a proud sponsor of the 2026 #NCBC Annual Meeting. We invite you to visit us at booth 200+201 to learn more about Ambry's #hereditarycancer testing and The Ambry #CARE Program®. Check out details on our oral presentation on high-risk identification or schedule a

Access to answers can change a life, and it should never depend on insurance type. We’re honored to support teams like Boston Medical Center in delivering genetic testing to all patients, helping families reach diagnoses sooner and unlock meaningful care. Thank you to Jodi D.

We’re honored to spotlight Gwenn O’Keeffe, MD, JD, FAAP, a pediatrician with Cortica Care. Dr. O’Keeffe shows up for her patients every single day, going above and beyond to identify the best path forward, including when genetic testing can offer better clarify and guidance for

This Rare Disease Day, Ambry recognizes the resilience of patients and families navigating long diagnostic journeys. We are committed to advancing equity in rare disease care by removing barriers to genetic testing and ensuring more patients can benefit from new discoveries,

Join us for a webinar on Wednesday, March 4, at 10 am PST. Overall cancer risk in an individual can vary widely due to a genetic and nongenetic factors. Dr. Tuya Pal discusses these factors and considerations around clinical intervention to either reduce cancer risk or initiate

“TBC1D24 disorder is so rare that it felt like we were the only ones living with it.” For JoeyLynn Nolan, finding a diagnosis didn’t just name her son’s condition, it opened the door to connection, understanding, and hope. In her Rare Disease Month reflection, she shares how

As Ambry recognizes Rare Disease Day on February 28, explore how we contribute to our commitment not to stop until rare disease is understood. https://t.co/I8wADO7TLZ

How does Progeny help genetic counselor Liam Riddle better serve patients with rare disease? Watch the video to find out! Dive deeper: https://t.co/FndMkcVCb5

Ambry is proud to be recognized in the Epidemiology and Genomics Research Program (EGRP) Research Highlights for 2025. Published in Nature, Functional evaluation and clinical classification of BRCA2 variants was designed to leverage CRISPR/cas-9 gene editing to aid in the

The journey with a genetic condition extends far beyond the initial diagnosis. Our Patient for Life™ program ensures you have a partner for every step that follows. We are committed to providing lifelong support through: 🌊New answers, not just reclassifications – When new

“When you learn that your child has a syndrome, it’s natural to be scared—but I want other parents to know it will be okay.” After her son Emmett’s diagnosis, Brittaney Carpenter turned fear into advocacy using answers, education, and community to help other families navigate

In this week's Gene Scene, Brooke Sample, MS, CGC, covers the RPE65 gene, which regulates an enzyme that is critical for the "visual cycle"—the process of regenerating light-sensitive pigments in the eye. Mutations in this gene cause RPE65-related retinopathies that vary in

Join us for a webinar on Thursday, February 19, at 11 am PST. Abby Turnwald, MS, CGC, and Sarah Jurgensmeyer, MS, CGC, will explain how genetics clinicians can support siblings of individuals with rare diseases in their practice. https://t.co/zBF9AXAlRN

Ambry Genetics is a proud sponsor of the 2026 ACMG Annual Meeting. We invite you to visit our booth to learn more about Ambry's #exome testing and Patient for Life™ and meet our experts in booth 517 to discuss where genomic insights meet clinical action. #ACMGMtg26